Results 281 to 290 of about 286,453 (328)
Some of the next articles are maybe not open access.

Pediatric Antiretroviral Therapy

2019
Human immunodeficiency virus (HIV) is one of the most serious pediatric infectious diseases, affecting around 3 million children and adolescents worldwide. Lifelong antiretroviral treatment (ART) provides multiple benefits including sustained virologic suppression, restoration and preservation of immune function, decreased morbidity and mortality, and ...
Sahera, Dirajlal-Fargo   +2 more
openaire   +2 more sources

Antiretroviral therapy

Journal of the American Academy of Dermatology, 1989
Research into the biology of human immunodeficiency virus type 1 (HIV-1), the causative agent of the acquired immunodeficiency syndrome, has yielded valuable information about the replicative cycle of the virus. The steps involved are (1) attachment of the virus to a receptor protein on the surface of the target cell, (2) entry of the virus into the ...
openaire   +2 more sources

Antiretroviral Therapy

2019
Abstract: This chapter is about antiretroviral therapy (ART). It includes the goals of antiretroviral therapy (according to the 2018 Department of Health and Human Services [DHHH] guidelines), and it covers recommendations for antiretroviral therapy, special co-factor considerations, and what antiretroviral regimen to start.
John G. Bartlett   +2 more
openaire   +1 more source

Intensification of Antiretroviral Therapy

AIDS Research and Human Retroviruses, 2001
ALTHOUGH IMPORTANT DEVELOPMENTS in antiretroviral treatment have occurred, the ability to durably suppress HIV replication is still quite limited. Current guidelines recommend the introduction of at least two compounds not included in the discontinued regimen for treatment failures.1–3 This approach is based on the assumption that resistance mutations ...
M, Núñez   +2 more
openaire   +2 more sources

Antiretroviral therapy and TB

Tropical Doctor, 2006
With the expansion and convergence of the HIV and TB epidemics worldwide, clinicians will increasingly will be called to manage and treat co-infected patients. TB and HIV medications have overlapping and additive toxicities that can complicate therapy.
Swaminathan, Soumya   +5 more
openaire   +2 more sources

Antiretroviral Therapy

1998
Abstract The last decade has brought continued advances in the use of agents that inhibit the human immunodeficiency viruses. It is now well established that antiretroviral therapy slows down the progression of acquired immunodeficiency syndrome (AIDS) and can prolong survival. However, the high replication rate of human immunodeficiency
openaire   +1 more source

Antiretroviral therapy. Sequencing antiretrovirals.

The AIDS reader, 2000
Sequencing of antiretroviral agents is of interest because the majority of HIV-infected individuals in clinical practice experience virologic rebound after 1 to 2 years of therapy. Sequencing strategies are based on the observation that different mutational patterns arise after exposure to particular antiretroviral agents within the same class and on ...
openaire   +1 more source

[Antiretroviral therapy].

Recenti progressi in medicina, 2003
The use of combinations of antiretroviral drugs can profoundly suppress HIV replication for prolonged periods and has substantially decreased AIDS-related morbidity and mortality. The optimal use of antiretroviral drugs remains a rapidly evolving field and numerous obstacles need to be addressed.
openaire   +1 more source

Antiretroviral therapy

Clinics in Dermatology, 1991
M K, Sachs, T E, Martynowicz
openaire   +2 more sources

Stopping antiretroviral therapy

AIDS, 2007
Stephen, Taylor   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy